Dual inhibition and monitoring of beta-amyloid fibrillation by a luminescent iridium(iii) complex

Current Alzheimer Research

Volumn 12, Issue 5, 2015, Pages 439-444

  Wong, Chun Yuen ^a   Chung, Lai Hon ^a   Lu, Lihua ^b   Wang, Modi ^b   He, Bingyong ^b   Liu, Li Juan ^c   Leung, Chung Hang ^c   Ma, Dik Lung ^b  

^a CITY UNIVERSITY OF HONG KONG   (Hong Kong)

^b HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^c University of Macau   (Macao)

Author keywords

Aggregation; Alzheimer's; Amyloid; Iridium; Luminescent probe

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; IRIDIUM COMPLEX; AMYLOID; AMYLOID BETA PROTEIN; IRIDIUM; NEUROPROTECTIVE AGENT; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; COMPLEX FORMATION; DRUG STRUCTURE; DRUG SYNTHESIS; LUMINESCENCE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTON NUCLEAR MAGNETIC RESONANCE; TRANSMISSION ELECTRON MICROSCOPY; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; METABOLISM; PROCEDURES;

ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PEPTIDES; IRIDIUM; LUMINESCENT MEASUREMENTS; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR STRUCTURE; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS;

EID: 84930891349     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/1567205012666150504144558     Document Type: Article

References (62)

1. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353-356 (2002).
2. Ballatore C, Lee VMY, Trojanowski JQ. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci 8: 663-672 (2007).
3. Wang Q, Yu X, Li L, Zheng J. Inhibition of amyloid-β aggregation in Alzheimer's disease. Curr Pharm Des 20: 1223-1243 (2014).
4. Cheng B, Gong H, Xiao H, Petersen RB, Zheng L, Huang K.L. Inhibiting toxic aggregation of amyloidogenic proteins: A therapeutic strategy for protein misfolding diseases. Biochim Biophys Acta 1830: 4860-4871 (2013).
5. Zhang M, Mao X, Yu Y, Wang CX, Yang YL, Wang C. Nanomaterials for reducing amyloid cytotoxicity. Adv Mater 25: 3780-3801 (2013).
6. Belluti F, Rampa A, Gobbi S, Bisi A. Small-molecule inhibitors/modulators of amyloid-β peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review. Expert Opin Ther Pat 23: 581-596 (2013).
7. Meggers E. Exploring biologically relevant chemical space with metal complexes. Curr Opin Chem Biol 11(3): 287-292 (2007).
8. Meggers E. Targeting proteins with metal complexes. Chem Commun (9): 1001-1010 (2009).
9. Meggers E. From conventional to unusual enzyme inhibitor scaffolds: the quest for target specificity. Angew Chem Int Ed 50(11): 2442-2448 (2011).
10. Gasser G, Ott I, Metzler-Nolte N. Organometallic anticancer compounds. J Med Chem 54(1): 3-25 (2010).
11. Ott I, Gust R. Non platinum metal complexes as anti-cancer drugs. Arch Pharm 340(3): 117-126 (2007).
12. Patel V, Zhang X, Tautiva NA, Nyabera1 AN, Owa OO, Baidya M et al. Small molecules and Alzheimer's disease: misfolding, metabolism and imaging. Curr Alzheimer Res 12(5): 445-460 (2015).
13. Yamin G, Ruchala P, Teplow DB. A peptide hairpin inhibitor of amyloid β -protein oligomerization and fibrillogenesis. Biochemistry 48(48): 11329-11331 (2009).
14. Taylor M, Moore S, Mayes J, Parkin E, Beeg M, Canovi M, et al. Development of a proteolytically stable retro-inverso peptide inhibitor of β -amyloid oligomerization as a potential novel treatment for Alzheimer's disease. Biochemistry 49(15): 3261- 3272 (2010).
15. Cohen T, Frydman-Marom A, Rechter M, Gazit E. Inhibition of amyloid fibril formation and cytotoxicity by hydroxyindole derivatives. Biochemistry 45(15): 4727-4735 (2006).
16. Reinke AA, Gestwicki JE. Structure-activity Relationships of amyloid beta-aggregation inhibitors based on curcumin: influence of linker length and flexibility. Chem Biol Drug Des 70(3): 206- 215 (2007).
17. Hong H-S, Rana S, Barrigan L, Shi A, Zhang Y, Zhou F, et al. Inhibition of Alzheimer's amyloid toxicity with a tricyclic pyrone molecule in vitro and in vivo. J Neurochem 108(4): 1097-1108 (2009).
18. Reinke AA, Ung PMU, Quintero JJ, Carlson HA, Gestwicki JE. et al. Chemical probes that selectively recognize the earliest aβ oligomers in complex mixtures. J Am Chem Soc 132(50): 17655- 17657 (2010).
19. Mishra R, Bulic B, Sellin D, Jha S, Waldmann H, Winter R. Small-molecule inhibitors of islet amyloid polypeptide fibril formation. Angew Chem Int Ed 47(25): 4679-4682 (2008).
20. Arai T, Araya T, Sasaki D, Taniguchi A, Sato T, Sohma Y, et al. Rational design and identification of a non-peptidic aggregation inhibitor of amyloid-β based on a pharmacophore motif obtained from cyclo[-Lys-Leu-Val-Phe-Phe-]. Angew Chem Int Ed Engl 2014 53(31): 8236-9 (2014).
21. Razavi H, Palaninathan SK, Powers ET, Wiseman RL, Purkey HE, Mohamedmohaideen NN, et al. Benzoxazoles as transthyretin amyloid fibril inhibitors: synthesis, evaluation, and mechanism of action. Angew Chem Int Ed 42(24): 2758-2761 (2003).
22. Sharma AK, Pavlova ST, Kim J, Finkelstein D, Hawco NJ, Rath NP, et al. Bifunctional compounds for controlling metal-mediated aggregation of the Aβ42 peptide. J Am Chem Soc 134(15): 6625- 6636 (2012).
23. Ho S-L, Poon C-Y, Lin C, Yan T, Kwong DW-J, Yung KK-L, et al. Inhibition of β-amyloid aggregation by albiflorin, aloeemodin and neohesperidin and their neuroprotective effect on primary hippocampal cells against β -amyloid induced toxicity. Curr Alzheimer Res 12(5): 424-433 (2015).
24. Lee HH, Choi TS, Lee SJC, Lee JW, Park J, Ko YH, et al. Supramolecular inhibition of amyloid fibrillation by cucurbit[7]uril. Angew Chem Int Ed Engl 53(29): 7461-5 (2014).
25. Geng J, Li M, Ren J, Wang E, Qu X. Polyoxometalates as inhibitors of the aggregation of amyloid β peptides associated with Alzheimer's disease. Angew Chem Int Edgl 50(18): 4184-4188 (2011).
26. Gao N, Sun H, Dong K, Ren J, Duan T, Xu C, et al. Transitionmetal- substituted polyoxometalate derivatives as functional antiamyloid agents for Alzheimer's disease. Nat Commun 5: 3422 (2014).
27. Yoo SI, Yang M, Brender JR, Subramanian V, Sun K, Joo NE, et al. Inhibition of amyloid peptide fibrillation by inorganic nanoparticles: functional similarities with proteins. Angew Chem Int Ed Engl 50(22): 5110-5115 (2011).
28. Xiao L, Zhao D, Chan W-H, Choi MM, Li HW. et al. Inhibition of beta 1-40 amyloid fibrillation with N-acetyl-l-cysteine capped quantum dots. Biomaterials 31(1): 91-98 (2010).
29. Kumar A, Moody L, Olaivar JF, Lewis NA, Khade RL, Holder AA, et al. Inhibition of Aβ42 peptide aggregation by a binuclear ruthenium(II)−platinum(II) complex: potential for multimetal organometallics as anti-amyloid agents. ACS Chem Neurosci 1(10): 691-701 (2010).
30. Barnham KJ, Kenche VB, Ciccotosto GD, Smith DP, Tew DJ, Liu X, et al. Platinum-based inhibitors of amyloid-β as therapeutic agents for Alzheimer's disease. Proc Natl Acad Sci USA 105(19): 6813-6818 (2008).
31. Kenche VB, Hung LW, Perez K, Volitakes I, Ciccotosto G, Kwok J, et al. Development of a platinum complex as an anti-amyloid agent for the therapy of Alzheimer's disease. Angew Chem Int Ed 52(12): 3374-3378 (2013).
32. Ma G, Huang F, Pu X, Jia L, Jiang T, Li L, et al. Identification of [PtCl2(phen)] binding modes in amyloid-β peptide and the mechanism of aggregation inhibition. Chem Eur J 17(41): 11657- 11666 (2011).
33. Ma G, Wang E, Wei H, Wei K, Zhu P, Liu Y. PtCl2(phen) disrupts the metal ions binding to amyloid-β peptide. Metallomics 5(7): 879-887 (2013).
34. Streltsov VA, Chandana Epa V, James SA, Churches QI, Caine JM, Kenche VB, et al. Structural insights into the interaction of platinum-based inhibitors with the Alzheimer's disease amyloid-β peptide. Chem Commun 49(97): 11364-11366 (2013).
35. Wang X, Wang X, Zhang C, et al. Inhibitory action of macrocyclic platiniferous chelators on metal-induced Aβ aggregation. Chem Sci 3(4): 1304-1312 (2012).
36. Collin F, Sasaki I, Eury H, Faller P, Hureau C. Pt(II) compounds interplay with Cu(II) and Zn(II) coordination to the amyloid-β peptide has metal specific consequences on deleterious processes associated to Alzheimer's disease. Chem Commun 49(21): 2130- 2132 (2013).
37. Vyas NA, Bhat SS, Kumbhar AS, Sonawane UB, Jani V, Joshi RR, et al. Ruthenium(II) polypyridyl complex as inhibitor of acetylcholinesterase and Aβ aggregation. Eur J Med Chem 75: 375- 381 (2014).
38. Valensin D, Anzini P, Gaggelli E, Gaggelli N, Tamasi G, Cini R, et al. fac-{Ru(CO)3}2+ selectively targets the histidine residues of the β-amyloid peptide 1-28. implications for new alzheimer's disease treatments based on ruthenium complexes. Inorg Chem 49(11): 4720-4722 (2010).
39. Messori L, Camarri M, Ferraro T, Gabbiani C, Franceschini D. Promising in vitro anti-Alzheimer Properties for a ruthenium(III) complex. ACS Med Chem Lett 4(3): 329-332 (2013).
40. Heffern MC, Velasco PT, Matosziuk LM, Coomes JL, Karras C, Ratner MA, et al. Modulation of amyloid-β aggregation by histidine-coordinating cobalt(III) schiff base complexes. ChemBioChem 15(11): 1584-1589 (2014).
41. Man BY-W, Chan H-M, Leung C-H, et al. Group 9 metal-based inhibitors of β-amyloid (1-40) fibrillation as potential therapeutic agents for Alzheimer's disease. Chem Sci 2(5): 917-921 (2011).
42. P, Xia C-L, Tan J-H, Li D, Ou T-M, Huang S-L, et al. Syntheses and evaluation of asymmetric curcumin analogues as potential multifunctional agents for the treatment of alzheimer's disease. Curr Alzheimer Res 12(5): 403-414 (2015).
43. Kochi A, Lee HJ, Vithanarachchi SM, Padmini V, Allen MJ, Lim MH. Inhibitory activity of curcumin derivatives towards metal-free and metal-induced amyloid-b aggregation. Curr Alzheimer Res 51(23): 12959-67 (2012).
44. SL-F, Lam TL, Lu L, Yan S-C, Leung C-H, Ma D-L. A novel tetradentate ruthenium(II) complex containing Tris(2- pyridylmethyl)amine (tpa) as an inhibitor of beta-amyloid fibrillation. Curr Alzheimer Res 12(5): 434-438 (2015).
45. Lorenzo A, Yankner BA. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc Natl Acad Sci USA 91(25): 12243-12247 (1994).
46. Sathish V, Babu E, Ramdass A, Lu ZZ, Velayudham M, Thanasekaran P, et al. Alkoxy bridged binuclear rhenium(I) complexes as a potential sensor for β-amyloid aggregation. Talanta 130(0): 274-279 (2014).
47. Cook NP, Torres V, Jain D, Marti AA. Sensing amyloid-β aggregation using luminescent dipyridophenazine ruthenium(II) complexes. J Am Chem Soc 133(29): 11121-11123 (2011).
48. Wong W-Y, Ho C-L. Organometallic Photovoltaics: A new and versatile approach for harvesting solar energy using conjugated polymetallaynes. Acc Chem Res 43(9): 1246-1256 (2010).
49. Thorp-Greenwood FL, Balasingham RG, Coogan MP. Organometallic complexes of transition metals in luminescent cell imaging applications. J Organomet Chem 714: 12-21 (2012).
50. Zhao Q, Li F, Huang C. Phosphorescent chemosensors based on heavy-metal complexes. Chem Soc Rev 39(8): 3007-3030 (2010).
51. Yang Y, Zhao Q, Feng W, Li F. Luminescent chemodosimeters for bioimaging. Chem Rev 113(1): 192-270 (2012).
52. Ma D-L, Ma VP-Y, Chan DS-H et al. Recent advances in luminescent heavy metal complexes for sensing. Coord Chem Rev 256(23-24): 3087-3113 (2012).
53. Gill MR, Thomas JA. Ruthenium(II) polypyridyl complexes and DNA-from structural probes to cellular imaging and therapeutics. Chem Soc Rev 41(8): 3179-3192 (2012).
54. Ma D-L, He H-Z, Leung K-H, Zhong HJ, Chan DS, Leung CH. Label-free luminescent oligonucleotide-based probes. Chem Soc Rev 42(8): 3427-3440 (2013).
55. Zhao Q, Huang C, Li F. Phosphorescent heavy-metal complexes for bioimaging. Chem Soc Rev 40(5): 2508-2524 (2011).
56. Ma D-L, Chan DS-H, Leung C-H. Group 9 organometallic compounds for therapeutic and bioanalytical applications. Acc Chem Res 47, 3614-3631 (2014).
57. Leung C-H, Zhong H-J, He H-Z, Lu L, Chan DS-H, Ma D-L. Luminescent oligonucleotide-based detection of enzymes involved with DNA repair. Chem Sci 4, 3781-3795 (2013).
58. Ma D-L, He H-Z, Chan DS-H and Leung C-H. Simple DNA-based logic gates responding to biomolecules and metal ions. Chem Sci 4, 3366-80 (2013).
59. He H-Z, Chan DS-H, Leung C-H, Ma D-L. G-quadruplexes for luminescent sensing and logic gates. Nucl Acids Res 41, 4345- 4359 (2013).
60. Raynal M, Cazin CSJ, Vallee C, Olivier-Bourbigou H, Braunstein P. An unprecedented, figure-of-eight, dinuclear iridium(I) dicarbene and new iridium(III) 'pincer' complexes. Chem Commun (34): 3983-3985 (2008).
61. Ban T, Hamada D, Hasegawa K, Naiki H, Goto Y. Direct observation of amyloid fibril growth monitored by thioflavin T fluorescence. J Biol Chem 278(19): 16462-16465 (2003).
62. Li Q, Min J, Ahn Y-H, Namm J, Kim EM, Lui R, Kim HY, et al. Styryl-based compounds as potential in vivo imaging agents for β- amyloid plaques. ChemBioChem 8(14): 1679-1687 (2007).